Coloplast A/S (OTCMKTS:CLPBY) Announces Earnings Results

Coloplast A/S (OTCMKTS:CLPBY) posted its quarterly earnings results on Tuesday. The company reported $0.09 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.09, Zacks reports. Coloplast A/S had a return on equity of 42.25% and a net margin of 10.57%. The business had revenue of $1.12 billion for the quarter, compared to analyst estimates of $1.12 billion.

Coloplast A/S Stock Down 0.6%

Shares of Coloplast A/S stock traded down $0.05 on Thursday, hitting $7.88. The company had a trading volume of 13,345 shares, compared to its average volume of 426,919. Coloplast A/S has a twelve month low of $5.64 and a twelve month high of $9.57. The company has a debt-to-equity ratio of 1.51, a current ratio of 1.56 and a quick ratio of 0.94. The stock has a 50-day moving average of $6.83 and a 200-day moving average of $6.80. The firm has a market capitalization of $17.76 billion, a P/E ratio of 37.52, a P/E/G ratio of 2.63 and a beta of 0.10.

Coloplast A/S Company Profile

Coloplast A/S is a Denmark-based medical technology company that develops, manufactures and markets products designed to help people manage intimate health conditions. Its core businesses include ostomy care, continence care, wound and skin care, and interventional urology. The company’s products are used by patients and healthcare professionals in hospitals, clinics and home-care settings.

Coloplast was founded in Denmark in 1957 after nurse Elise Sørensen helped develop an adhesive ostomy bag for her sister, who had undergone surgery.